# FDA recall D-0012-2025

> **Bionpharma Inc.** · Class I · drug recall initiated 2024-09-17.

## Product

Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.

## Reason for recall

Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.

## Distribution

Nationwide in the U.S.A.

## Key facts

- **Recall number:** D-0012-2025
- **Recalling firm:** Bionpharma Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2024-09-17
- **Report date:** 2024-10-23
- **Termination date:** 2025-09-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0012-2025

## Citation

> AI Analytics. FDA recall D-0012-2025. Retrieved 2026-08-11 from https://api.ai-analytics.org/recall/D-0012-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*